GE Healthcare is rolling out a new dedicated nuclear medicine scanner called MyoSPECT. The system sports an extended field of view and automated workflow, as well as detectors based on digital cadmium zinc telluride (CZT) technology.
GE notes that cardiac imaging now accounts for 50% of all nuclear medicine studies in the U.S., as the number of individuals diagnosed and dying from cardiovascular disease increases. This has created the need for cardiac-specific imaging technologies that are well-suited for patients of all sizes, according to the company.
MyoSPECT meets this need with a wider patient table and a field-of-view volume that's 76% larger than the company's Discovery NM 350c nuclear cardiac scanner. This should give clinicians better flexibility in positioning patients, especially those who are too weak to sit up or who have high body mass index, according to the company.
Meanwhile, MyoSPECT's CZT detectors and pinhole collimator design result in high energy and spatial resolution, and the system can perform a tomographic imaging arc of the heart with motionless detectors, such that each detector focuses on the heart simultaneously.
The scanner also includes GE's Smart Positioning protocol, as well as Alcyone motion detection and correction on the company's Xeleris processing and review workstation, producing images with fewer motion artifacts. Also available is SPECT Flow, which combines dynamic acquisition on the scanner with measurements of coronary flow reserve and absolute myocardial blood flow.
GE is highlighting MyoSPECT at this week's American Society of Nuclear Cardiology, September 30 to October 3.